Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Contract revenue $ 1,096
Costs and Expenses:    
Research and development 3,446 3,970
General and administrative 2,456 2,712
Total costs and expenses 5,902 6,682
Loss from operations (5,902) (5,586)
Other income, net 78 73
Net loss $ (5,824) $ (5,513)
Net loss per share - basic $ (0.03) $ (0.03)
Net loss per share - diluted $ (0.03) $ (0.03)
Weighted average common shares outstanding:    
Weighted average common shares outstanding - basic 217,358,085 217,264,526
Weighted average common shares outstanding - diluted 217,358,085 217,264,526
Other comprehensive gain, net of tax    
Unrealized gain on securities available-for-sale $ 87 $ 229
Other comprehensive gain, net of tax 87 229
Comprehensive loss $ (5,737) $ (5,284)